BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35723810)

  • 1. Silencing CircEIF3I/miR-526b-5p Axis Epigenetically Targets HGF/c-Met Signal to Hinder the Malignant Growth, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Liu Y; Xiao X; Wang J; Wang Y; Yu Y
    Biochem Genet; 2023 Feb; 61(1):48-68. PubMed ID: 35723810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 3. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01343 targets miR-526b-5p to facilitate the development of hepatocellular carcinoma by upregulating ROBO1.
    Wu S; Tang T; Zhou H; Huang J; Kang X; Zhang J
    Sci Rep; 2023 Oct; 13(1):17282. PubMed ID: 37828032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway.
    Tian Y; Han W; Lv K; Fu L; Zhou X
    Sci Rep; 2024 Apr; 14(1):8243. PubMed ID: 38589413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircSOD2 Contributes to Tumor Progression, Immune Evasion and Anti-PD-1 Resistance in Hepatocellular Carcinoma by Targeting miR-497-5p/ANXA11 Axis.
    Ye R; Lu X; Liu J; Duan Q; Xiao J; Duan X; Yue Z; Liu F
    Biochem Genet; 2023 Apr; 61(2):597-614. PubMed ID: 36008700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
    Liu W; Yin C; Liu Y
    Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
    [No Abstract]   [Full Text] [Related]  

  • 9. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
    Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1.
    Wu S; Tang T; Zhou H; Huang J; Kang X; Zhang J
    Cancer Biol Ther; 2023 Dec; 24(1):2256951. PubMed ID: 37773733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA circUGGT2 Contributes to Hepatocellular Carcinoma Development via Regulation of the miR-526b-5p/RAB1A Axis.
    Kong Q; Fan Q; Ma X; Li J; Ma R
    Cancer Manag Res; 2020; 12():10229-10241. PubMed ID: 33116877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27.
    Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X
    Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
    Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
    Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
    Fu D; Ji Q; Wang C; Yu L; Yu R
    Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Liu J; He X; Zou Y; Wang K
    Dig Dis Sci; 2022 Jun; 67(6):2269-2282. PubMed ID: 34231101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.